CAPTRUST Financial Advisors
RGNX icon

CAPTRUST Financial Advisors’s Regenxbio RGNX Stock Holding History

CAPTRUST Financial Advisors’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$159K Sell
13,235
-1,033
-7% -$8.57K ﹤0.01% 2945
2026
Q1 		$120K Sell
14,268
-960
-6% -$10.1K ﹤0.01% 2783
2025
Q4 		$219K Buy
15,228
+1,781
+13% +$22.2K ﹤0.01% 2465
2025
Q3 		$130K Buy
13,447
+3,033
+29% +$26.8K ﹤0.01% 2488
2025
Q2 		$85.5K Buy
+10,414
New +$87.2K ﹤0.01% 2383
2022
Q3 		– Sell
-607
Closed -$15K – 3618
2022
Q2 		$15K Sell
607
-353
-37% -$8.82K ﹤0.01% 3538
2022
Q1 		$32K Buy
960
+846
+742% +$23.5K ﹤0.01% 3106
2021
Q4 		$4K Buy
114
+14
+14% +$477 ﹤0.01% 4187
2021
Q3 		$4K Buy
100
+21
+27% +$756 ﹤0.01% 4049
2021
Q2 		$3K Sell
79
-13
-14% -$465 ﹤0.01% 4052
2021
Q1 		$3K Buy
92
+37
+67% +$1.58K ﹤0.01% 3935
2020
Q4 		$2K Buy
55
+25
+83% +$874 ﹤0.01% 3146
2020
Q3 		$1K Buy
+30
New +$978 ﹤0.01% 2947

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

CAPTRUST Financial Advisors's RGNX Position: Q2 2026 in Review

CAPTRUST Financial Advisors reduced its Regenxbio (RGNX) stake by 7.2% in Q2 2026, selling an estimated $8.57K and leaving 13,235 shares worth $159K. The position accounts for ﹤0.01% of the portfolio, ranked #2945.

CAPTRUST Financial Advisors first reported a position in RGNX in Q3 2020 and has held it in 13 quarters since. The position peaked at $219K in Q4 2025. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • CAPTRUST Financial Advisors held 13,235 shares of Regenxbio worth $159K as of Q2 2026.
  • CAPTRUST Financial Advisors sold 1,033 Regenxbio shares in Q2 2026, an estimated $8.57K.
  • Regenxbio made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #2945 holding.
  • CAPTRUST Financial Advisors first reported a position in Regenxbio in Q3 2020 and has held it in 13 quarters since.
  • CAPTRUST Financial Advisors's Regenxbio position peaked at $219K in Q4 2025.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.